XML 55 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Segment Information - Operating Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Biological Indicators [Member]        
Revenues $ 7,819 $ 6,964 $ 23,537 $ 19,822
Gross profit 4,869 4,194 15,157 12,029
Selling expenses 505 365 1,372 766
Gross profit after deducting selling expense and impairment of intangible asset $ 4,364 $ 3,829 $ 13,785 $ 11,263
Reconciling items (1) [1] [1]
Earnings before income taxes
Instruments [Member]        
Revenues $ 8,260 $ 8,216 $ 25,819 $ 24,966
Gross profit 5,511 5,412 16,571 15,794
Selling expenses 784 919 2,975 3,093
Gross profit after deducting selling expense and impairment of intangible asset $ 4,727 $ 4,493 $ 13,596 $ 12,701
Reconciling items (1) [1] [1]
Earnings before income taxes
Continuous Monitoring [Member]        
Revenues $ 2,595 $ 2,650 $ 7,412 $ 7,982
Gross profit 1,254 1,446 3,246 4,057
Selling expenses 132 488 1,098 1,318
Gross profit after deducting selling expense and impairment of intangible asset $ 1,122 $ 958 $ 2,148 $ 2,739
Reconciling items (1) [1] [1]
Earnings before income taxes
Cold Chain [member]        
Revenues $ 1,239   $ 3,079  
Gross profit 575   1,443  
Selling expenses 96   159  
Gross profit after deducting selling expense and impairment of intangible asset $ 479   $ 1,284  
Reconciling items (1) [1] [1]
Earnings before income taxes
Revenues $ 19,913 $ 17,830 $ 59,847 $ 52,770
Gross profit 12,209 11,052 36,417 31,880
Selling expenses 1,517 1,772 5,604 5,177
Gross profit after deducting selling expense and impairment of intangible asset 10,692 9,280 30,813 26,703
Reconciling items (1) (7,241) [1] (5,567) [1] (21,043) (15,354)
Earnings before income taxes $ 3,451 $ 3,713 $ 9,770 $ 11,349
[1] Reconciling items include general and administrative, research and development, and other expenses.